HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Augustine Goba Selected Research

Lassa Fever (Fever, Lassa)

11/2021Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
1/2020Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone.
1/2020Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
4/2019Data set on Lassa fever in post-conflict Sierra Leone.
12/2018Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
10/2017Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.
10/2016Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
1/2016Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.
10/2011Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
12/2010Ribavirin for Lassa fever postexposure prophylaxis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Augustine Goba Research Topics

Disease

12Lassa Fever (Fever, Lassa)
11/2021 - 06/2008
10Infections
01/2021 - 11/2010
6Fever (Fevers)
10/2016 - 05/2010
3Ebola Hemorrhagic Fever
01/2020 - 10/2016
2Cataract (Cataracts)
01/2021 - 04/2018
2Viremia
10/2011 - 11/2010
1COVID-19
11/2021
1Severe Acute Respiratory Syndrome
11/2021
1Vesicular Stomatitis
10/2020
1Uveitis
04/2018
1Epidemic Louse-Borne Typhus (Typhus)
02/2015
1Diarrhea
11/2014
1Dizziness (Lightheadedness)
11/2014
1Acute Disease
07/2014
1Dengue (Dengue Fever)
07/2014
1Rift Valley Fever
07/2014
1Yellow Fever
07/2014
1Smallpox (Variola)
10/2011
1Inflammation (Inflammations)
10/2011
1Virus Diseases (Viral Diseases)
11/2010

Drug/Important Bio-Agent (IBA)

8AntigensIBA
10/2020 - 10/2011
6Immunoglobulin M (IgM)IBA
01/2020 - 10/2011
5AntibodiesIBA
11/2021 - 07/2014
5Immunoglobulin G (IgG)IBA
01/2020 - 10/2011
4VaccinesIBA
01/2020 - 05/2010
4Monoclonal AntibodiesIBA
01/2020 - 01/2016
3Proteins (Proteins, Gene)FDA Link
11/2021 - 11/2010
3RNA (Ribonucleic Acid)IBA
01/2021 - 05/2010
3Glycoproteins (Glycoprotein)IBA
01/2020 - 11/2010
3Ribavirin (Virazole)FDA LinkGeneric
04/2019 - 12/2010
2ImmunosorbentsIBA
11/2021 - 02/2015
2EnzymesIBA
11/2021 - 02/2015
1EpitopesIBA
11/2021
1Protein CIBA
11/2020
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2020
1Recombinant ProteinsIBA
01/2020
1ZincIBA
01/2020
1NucleoproteinsIBA
01/2020
1NitrogenIBA
11/2014
1CreatinineIBA
11/2014
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2014
1Urea (Carbamide)FDA LinkGeneric
11/2014
1Nucleic AcidsIBA
10/2011
1Protein Isoforms (Isoforms)IBA
11/2010
1Viral AntigensIBA
11/2010
1DNA (Deoxyribonucleic Acid)IBA
05/2010
1Antiviral Agents (Antivirals)IBA
05/2010
1Indicators and Reagents (Reagents)IBA
06/2008

Therapy/Procedure

2Therapeutics
10/2017 - 11/2010
1Aftercare (After-Treatment)
01/2021